The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phased variants improve DLBCL minimal residual disease detection at the end of therapy.
 
David Matthew Kurtz
Stock and Other Ownership Interests - Foresight Diagnostics
Consulting or Advisory Role - Genentech; Roche Molecular Diagnostics
Patents, Royalties, Other Intellectual Property - Dr. Kurtz has patents pending related to methods for analysis of cell free nucleic acids and methods for treatment selection based on statistical frameworks of clinical outcome.
 
Jacob J. Chabon
Employment - Foresight Diagnostics
Leadership - Foresight Diagnostics
Stock and Other Ownership Interests - Foresight Diagnostics
Patents, Royalties, Other Intellectual Property - Patents related to detection of circulating tumor DNA
 
Joanne Soo
No Relationships to Disclose
 
Lyron Co Ting Keh
No Relationships to Disclose
 
Stefan Alig
No Relationships to Disclose
 
Andre Schultz
Employment - Unimed (I)
Stock and Other Ownership Interests - 10X Genomics; GlaxoSmithKline
 
Michael C. Jin
No Relationships to Disclose
 
Florian Scherer
No Relationships to Disclose
 
Alexander F.M. Craig
No Relationships to Disclose
 
Chih Long Liu
No Relationships to Disclose
 
Ulrich Duehrsen
Honoraria - Amgen; CPT Cellex Patient Treatment; Janssen-Cilag; Novartis; Roche Pharma AG
Consulting or Advisory Role - Abbvie; Gilead Sciences; Takeda
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Abbvie; Janssen-Cilag
 
Andreas Huettmann
Honoraria - Takeda
Consulting or Advisory Role - Takeda
Travel, Accommodations, Expenses - Roche Pharma AG; Takeda
 
René-Olivier Casasnovas
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Merck; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Gilead Sciences; Incyte; Janssen; Merck; Roche/Genentech; Takeda
Research Funding - Gilead Sciences (Inst); Roche/Genentech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Janssen; Roche/Genentech; Takeda
 
Jason Westin
Consulting or Advisory Role - ADC Therapeutics; Amgen; Bristol-Myers Squibb; Celgene; Curis; Forty Seven; Genentech/Abbvie; Iksuda Therapeutics; IMV; Janssen Scientific Affairs; Juno Therapeutics; Karyopharm Therapeutics; Kite/Gilead; MorphoSys; Novartis
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Curis; Forty Seven; Genentech; Janssen; Kite/Gilead; MorphoSys; Novartis
 
Mark J. Roschewski
No Relationships to Disclose
 
Wyndham Hopkins Wilson
No Relationships to Disclose
 
Gianluca Gaidano
Honoraria - Abbvie; AstraZeneca; Janssen
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen
Speakers' Bureau - Abbvie; Janssen
Travel, Accommodations, Expenses - Janssen
 
Davide Rossi
Honoraria - Abbvie; AstraZeneca; AstraZeneca; Janssen
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Janssen (Inst)
 
Maximilian Diehn
Stock and Other Ownership Interests - CiberMed; Foresight Diagnostics
Consulting or Advisory Role - AstraZeneca; BioNTech; Genentech; Gritstone Bio; Illumina; Novartis; Reflexion Medical; Roche
Research Funding - Illumina; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection assigned to Stanford University (Inst); Patent filings on tumor treatment resistance mechanisms assigned to Stanford University (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche; Varian Medical Systems
 
Ash A. Alizadeh
Leadership - Lymphoma Research Foundation
Stock and Other Ownership Interests - CAPP Medical; CiberMed; Forty Seven
Honoraria - Janssen Oncology; Janssen Oncology; Roche
Consulting or Advisory Role - Celgene; Cibermed; Foresight Diagnostics; Foresight Diagnostics; Foresight Diagnostics; Gilead Sciences; Roche/Genentech
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection, assigned to Stanford University. (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche